McGregor Marion, Cambron Jerrilyn A, Jedlicka James, Gudavalli M Ram
Canadian Memorial Chiropractic College, Toronto, Ontario, Canada.
Contemp Clin Trials. 2009 Jan;30(1):20-3. doi: 10.1016/j.cct.2008.08.004. Epub 2008 Aug 31.
A major issue in clinical trials in manual medicine is treatment variability. The challenge is to insure that the bounded treatment options are both representative of field practitioner behavior and consistent among research clinicians. This investigation assesses the treatment comparability of field practitioners and research clinicians, for a flexion-distraction treatment procedure, as quality control for a randomized clinical trial.
Using a series of vignettes, we studied the level of agreement of treatment protocols between field clinicians, research clinicians and a reference clinician regarding treatment location, range of motion during treatment, and number of repetitions used within the flexion-distraction protocol.
Results indicated that reliability around decision making for anticipated location of spinal treatment was highest regardless of clinician group. For the research clinicians this level of agreement was ICC=0.88. Decision-making for treatment direction was second highest, at kappa=0.64 for the research clinicians. Reliability around the number of repetitions is poor ranging from ICC=0.18 to 0.34 depending on clinician type.
Understanding the disparity in treatment protocols is of value in the construction and maintenance of quality control in an actual randomized clinical trial setting. More work was recommended in the preparation of clinical trials and the understanding of clinical decision-making because these disparate factors may dramatically impact the generalizability of clinical trial results.
手法医学临床试验中的一个主要问题是治疗变异性。挑战在于确保有限的治疗方案既代表现场从业者的行为,又在研究临床医生之间保持一致。本研究评估现场从业者和研究临床医生在屈曲-牵张治疗程序上的治疗可比性,作为一项随机临床试验的质量控制。
我们使用一系列案例 vignettes,研究了现场临床医生、研究临床医生和一位参考临床医生在治疗部位、治疗期间的活动范围以及屈曲-牵张方案中使用的重复次数方面治疗方案的一致程度。
结果表明,无论临床医生组如何,脊柱治疗预期部位决策的可靠性最高。对于研究临床医生,这种一致程度的组内相关系数(ICC)为 0.88。治疗方向的决策可靠性次之,研究临床医生的卡方值(kappa)为 0.64。重复次数的可靠性较差,根据临床医生类型,组内相关系数在 0.18 至 0.34 之间。
了解治疗方案的差异对于在实际随机临床试验环境中构建和维持质量控制具有重要意义。建议在临床试验准备和临床决策理解方面开展更多工作,因为这些不同因素可能会极大地影响临床试验结果的可推广性。